Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2006
07/13/2006US20060154246 Encoded self-assembling chemical libraries (esachel)
07/13/2006US20060154244 Novel g-protein coupled receptor
07/13/2006US20060153902 Genration of phytase for use in animal feeds; obtain genetically engineered yeast, express vector, recover phytase
07/13/2006US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment
07/13/2006US20060153881 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria
07/13/2006US20060153879 Streptococcal C5a peptidase vaccine
07/13/2006US20060153875 Novel brachyspira hyodyseteriae vaccine
07/13/2006US20060153871 vaccine comprising the virus; immunization; diagnostic method comprising contacting a physiological sample of an animal suspected of containing antiinfluenza virus antibodies with the claimed virus
07/13/2006US20060153865 Antigenic peptides
07/13/2006US20060153860 Single chain Fv fragments which bind epidermal growth factor receptors and/or HER2 genes; pharmacokinetics
07/13/2006US20060153853 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics
07/13/2006US20060153851 CLASP proteins
07/13/2006US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics
07/13/2006US20060153831 Antithrombosis enzyme from the snake venom of Agkistrodon acutus
07/13/2006US20060153827 Chimeric protein
07/13/2006US20060153806 Proteins involved in the regulation of energy homeostasis
07/13/2006US20060153802 Mammalian chemokine reagents
07/13/2006US20060153800 DNA immunization with recombinase/transposase
07/13/2006CA2594223A1 Primer for nucleic acid detection
07/13/2006CA2593238A1 Method to trigger rna interference
07/13/2006CA2590462A1 Methods for expression and purification of recombinant human growth hormone
07/13/2006CA2588644A1 Inhibition of li expression in mammalian cells
07/13/2006CA2567599A1 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
07/12/2006EP1679383A2 Method and device for purifying nucleid acids
07/12/2006EP1679080A2 Prevention and treatment of amyloidogenic disease
07/12/2006EP1678328A2 Ntrk1 genetic markers associated with age of onset of alzheimer's disease
07/12/2006EP1678316A2 Campylobacter polypeptides and methods of use
07/12/2006EP1678303A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency
07/12/2006EP1678302A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells
07/12/2006EP1678207A1 Regulation of matrix metalloproteinases by psp94 family members
07/12/2006EP1678202A1 Hcv ns3-ns4a protease resistance mutants
07/12/2006EP1678195A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
07/12/2006EP1678194A1 The moduilation of hyaluronan synthesis and degradation in the treatment of disease
07/12/2006EP1678193A1 Hepatocellular carcinoma specific promoter and uses thereof
07/12/2006EP1677815A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization.
07/12/2006EP1677666A2 Diagnostic system for otolaryngologic pathogens and use thereof
07/12/2006EP1470158B1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
07/12/2006EP1124950B1 Morpholino based p53 antisense oligonucleotide, and uses thereof
07/12/2006EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression
07/12/2006EP0983288B1 Synthesis of oligonucleotides
07/12/2006EP0756488B1 Detection of alterations of tumor suppressor genes for the diagnosis of cancer
07/12/2006CN1802439A Use of a type III restriction enzyme to isolate identification tags comprising more than 25 nucleotides
07/12/2006CN1802438A Method and composition for detecting SARS virus
07/12/2006CN1800854A Gold-labeled test paper strip for quick diagnosis of hemorrhagic fever with renal syndrome
07/12/2006CN1800409A Exiguobacterium sp. MY02 strain pyrimidine nucleoside phosphorylase gene and its preparation method
07/12/2006CN1800387A Small interfering RNA for suppressing multiple effect growth factor expression and its uses
07/12/2006CN1800359A Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
07/12/2006CN1800210A Compounds for treatment of infectious and immune system disorders and methods for their use
07/12/2006CN1263864C Recombinant adenoviral vector and methods of use
07/12/2006CN1263851C Heavy PSME1 gene for pig to pass breast, and its Preparation method
07/12/2006CN1263767C SARS virus resisting si RNA and its application
07/12/2006CN1263766C Seed-specific promoter sequence separated from soya bean and its application
07/11/2006US7074916 Concurrently separating double and single stranded polynucleotide sequences present in mixture via absorption of nucleic acids to mineral support; in vitro transcription
07/11/2006US7074915 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
07/11/2006US7074914 Bactericides; polypeptides; genetic engineering
07/11/2006US7074913 Receptor for B anthracis toxin
07/11/2006US7074912 Identification and isolation of DNA and recombinant production of polypeptides
07/11/2006US7074911 Comprises nucleotide sequences coding tumor protease which is are activated when inserted into genome in association with alternative promoters or transcriptional start sites; gene therapeutic tools for treatment of metabolic and cancer defects
07/11/2006US7074910 PRO4340 nucleic acids
07/11/2006US7074909 Prevent, therapy of disease; isolated nucleic acid which codes antibody; binding to human antigen
07/11/2006US7074908 Protein for use in the treatment of lysosomal storage defects
07/11/2006US7074898 Polypeptide for use as an antiproliferative agent in the treatment of cell proliferative disorders
07/11/2006US7074895 Sequences characteristic of hypoxia-regulated gene transcription
07/11/2006US7074769 Antisense oligonucleotide or analog thereof comprising 10 or more contiguous bases or base analogs; for treating cancer
07/11/2006US7074768 Modified protein kinase A-specific oligonucleotides and methods of their use
07/11/2006US7074755 Immobilization of erythropoietin; increase reticulocyte production in bone marrow; anemia therapy
07/11/2006US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells
07/11/2006US7074614 Clock gene BMAL2
07/11/2006US7074607 Polynucleotide sequences which encode the zwa1 gene
07/11/2006US7074606 Microorganism utilizing propionamide for use in preparation of therapeutic amides
07/11/2006US7074605 Alpha-n-acetylgalactosaminidase for use in transfusion therapy
07/11/2006US7074604 Bioproduction of astaxanthin using mutant carotenoid ketolase and carotenoid hydroxylase genes
07/11/2006US7074602 Escherichia coli (E. coli) strain capable of producing L-threonine in high yield; expression repression of threonine biosynthesis genes by a metJ gene product is prevented, thereby producing a high concentration of threonine
07/11/2006US7074601 Nucleozymes
07/11/2006US7074599 Detection of mecA-containing Staphylococcus spp.
07/11/2006US7074597 Detecting single nucleotide polymorphisms
07/11/2006US7074596 For research, commercial production of polypeptides in an in vitro translation system
07/11/2006US7074591 Polynucleotides encoding human GABA receptors
07/11/2006US7074590 Chimeric promoters
07/11/2006US7074587 Astaxanthin synthase
07/11/2006US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies
07/11/2006US7074569 Mobility-modified nucleobase polymers and methods of using same
07/11/2006US7074568 using primers generated to the internal transcribed spacer sequence of 16S-23S rDNA that specifically amplify mycobacteria other than tuberculosis (MOTT); kits
07/11/2006US7074567 Assay for human DNA for gender determination
07/11/2006US7074565 Preparation of DNA-containing extract for PCR amplification
07/11/2006US7074561 Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mRNA
07/11/2006US7074560 Purification of tissue plasminogen activator (tPA)
07/11/2006US7074559 Comprises nucleotide sequences coding mycobacterium paratuberculosis polypeptides for immunization and prevention of mycobacterial animal infections
07/11/2006US7074410 Modified HCV peptide vaccines
07/11/2006US7074401 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
07/11/2006US7074400 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
07/11/2006US7074333 Separation and/ or fractionation of double stranded linear nucleic acids using continuous pressure differential ultrafiltration to achieve improved recovery of small PCR products
07/11/2006CA2352490C Magnetic particles for purifying nucleic acids
07/11/2006CA2246783C Mcbi analogs of cc-1065 and the duocarmycins
07/11/2006CA2182273C L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
07/06/2006WO2006072078A2 Bioproduction of astaxanthin using mutant carotenoid ketolase and cartonenoid hydroxylase genes
07/06/2006WO2006071949A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
07/06/2006WO2006071840A2 Formulations of human growth hormone comprising a non-naturally encoded amino acid
07/06/2006WO2006071028A1 Method for preparing transformants expressing benzaldehyde dehydrogenase and prepation of 2,6-naphthalene dicarboxylic acid using the transformants
07/06/2006WO2006031689A3 Multimeric constructs